Insecticides India Board Approves FY26 Results, Appoints New Director
Insecticides (India) Limited approved audited financial results for FY26. The company formulated an Employee Stock Purchase Scheme 2026 and appointed Mr. Sanskar Aggarwal as Additional Whole Time Director. Mrs. Nikunj Aggarwal resigned. The 29th AGM is scheduled for August 12, 2026.
The approval of financial results and the formulation of an employee stock purchase scheme are material events. The appointment of a new director and resignation of another are also significant corporate actions.
The announcement reports on routine board meeting outcomes, including financial results and personnel changes, without significant positive or negative financial impact.
Insecticides (India) Limited announced the outcome of its Board Meeting held on May 28, 2026. The Board approved the Audited Financial Results for the Quarter and Year ended March 31, 2026, with an unmodified audit opinion.
Key decisions included the formulation of the Employee Stock Purchase Scheme 2026 ("IIL ESPS Scheme 2026"), allowing for the issuance of up to 2,00,000 equity shares, subject to shareholder approval at the upcoming 29th Annual General Meeting (AGM).
The company also noted the resignation of Mrs. Nikunj Aggarwal as Whole Time Director. Subsequently, Mr. Sanskar Aggarwal was appointed as an Additional Whole Time Director for a term of five years, effective May 28, 2026, subject to shareholder approval.
Further appointments include Mr. Atul Kumar as Vice President - Sales (North) and M/s. T Jain & Associates as Internal Auditors for a five-year term from April 1, 2026, to March 31, 2031.
The 29th AGM of the Company is scheduled to be held on Wednesday, August 12, 2026, at 03:00 PM through Video Conferencing.
What to do with a filing like this
Insecticides (India) Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Insecticides (India) Limited. Read the original for the full detail.